C8-ceramide (3 μM; 48 hours) irreversibly reduces tumor-cell proliferation and induces morphological changes.
C8-ceramide can induce necrosis-like cell death, but does not induce caspase-dependent cleavage of PARP (biochemical marker of apoptosis) in human cervical tumor cells.
C8-ceramide may increase the endogenous ROS level (10-30 µM; 24 hours) by regulating the switch of SOD1 and SOD2, causing the anti-proliferation (10-50 µM; 24 hours), and consequently triggering the apoptosis (10-50 µM; 48 hours) of NSCLC H1299 cells.
Cell Viability Assay
Cell Line: |
CALO cells, INBL cells, HeLa cells |
Concentration: |
3 μM |
Incubation Time: |
48 hours |
Result: |
Markedly reduced the tumor cell number. |
Cell Proliferation Assay
Cell Line: |
H1299 cells |
Concentration: |
10 µM, 20 µM, 30 µM, 40 µM, 50 µM |
Incubation Time: |
24 hours |
Result: |
Decreased the rate of cellular proliferation in a dose-dependent manner, with an IC50 of 22.9 µM. |
Cell Cycle Analysis
Cell Line: |
H1299 cells |
Concentration: |
10 µM, 20 µM, 30 µM, 40 µM, 50 µM |
Incubation Time: |
24 hours |
Result: |
Caused the G1 arrest. |
Apoptosis Analysis
Cell Line: |
H1299 cells |
Concentration: |
10 µM, 20 µM, 30 µM |
Incubation Time: |
24 hours, 48 hours |
Result: |
Increased the level of cleaved caspase-3. |